Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
Value Health. 2014 Nov;17(7):A387.
doi: 10.1016/j.jval.2014.08.2653.
Epub 2014 Oct 26.